Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer

NCT02352571 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm Metastasis
Gastric Cancer
Colorectal Cancer

Interventions

BIOLOGICAL: GC1118

Sponsor

Green Cross Corporation